View Clinical Trial (Medical Research Study)
Metformin for Weight Loss in Schizophrenia - NCT01177709-10035(Clinical Trial 721701)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
New York |
|
State:
|
|
NY |
| Zip Code: |
|
10035 |
| Conditions: |
|
Schizophrenia - Obesity |
| Purpose: |
|
Study hypothesis is that patients on antipsychotics medication treated with metformin will
show loss in weight and improved measures of glucose metabolism.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Patients will be 18-70 years of age;
- Currently hospitalized or an outpatient at MPC;
- BMI ≥ 35 or excessive recent weight gain ( > than 10 lb weight gain in the past 3
months);
- Patients will have a diagnosis of schizophrenia or schizoaffective disorder or
bipolar disorder.
Exclusion Criteria:
- Age below 18 or over 70;
- Patient is currently already treated with metformin. |
|
|
|
| Study is available at: |
|
Manhatan Psychiatric Center
New York, NY 10035
United States
Primary Contact:
Robert C Smith, MD, PhD
Email: robert.smith@med.nyu.edu
Phone: 646-672-6910 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 23, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|